EIR Sun Pharmaceutical Industries Jun 2012

Mural Gavini FDA, Scott Laufenberg FDA$595.00 - Available Now

FDA investigators audited the Sun Pharmaceutical Industries - Halol, India facility and issued inspectional observation (via FDA 483) on 13 Jun 2012.

Product details

  • Category:
  • Inspection end: 13 Jun 2012
  • Location: Halol, India
  • FEI: 3002809586
Add To Cart